| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
DE:FRE
Fresenius SE & Co. KGaA
|
Oct 23, 2026 | BUY |
Strong Buy
+8.4% avg upside
21 analysts
|
$54.00
13.02% Upside
|
+13.0% | Β· |
|
QGEN
Qiagen
|
Oct 22, 2026 | HOLD |
Buy
-10.5% avg upside
25 analysts
|
$52.11
3.82% Upside
|
-0.2% | Β· |
|
SE:SOBI
Swedish Orphan Biovitrum AB
|
Oct 19, 2026 | BUY |
Strong Buy
-7.0% avg upside
7 analysts
|
$570.00
16.35% Upside
|
+11.2% | Β· |
|
BNTX
BioNTech SE
|
Oct 07, 2026 | BUY |
Strong Buy
+48.9% avg upside
28 analysts
|
$140.00
58.80% Upside
|
-9.3% | Β· |
|
DE:SRT3
Sartorius
|
Oct 07, 2026 | BUY |
Strong Buy
-0.2% avg upside
19 analysts
|
$280.00
4.09% Downside
|
+17.5% | Β· |
|
CH:TECN
Tecan Group AG
|
Oct 02, 2026 | BUY |
Buy
+36.3% avg upside
9 analysts
|
$300.00
21.53% Upside
|
+5.8% | Β· |
|
DE:FME
Fresenius Medical Care AG & Co. KGaA
|
Sep 29, 2026 | HOLD |
Hold
+22.7% avg upside
24 analysts
|
$42.00
4.04% Upside
|
+6.7% | Β· |
|
MRNA
Moderna
|
Sep 10, 2026 | HOLD |
Hold
-48.5% avg upside
38 analysts
|
$100.00
54.98% Downside
|
+69.3% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.